MannKind Corp (MNKD)
6.80
-0.22
(-3.13%)
USD |
NASDAQ |
Nov 15, 16:00
6.81
+0.01
(+0.15%)
After-Hours: 20:00
MannKind Research and Development Expense (TTM): 43.99M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 43.99M |
| June 30, 2024 | 41.05M |
| March 31, 2024 | 35.69M |
| December 31, 2023 | 31.28M |
| September 30, 2023 | 29.20M |
| June 30, 2023 | 23.35M |
| March 31, 2023 | 21.79M |
| December 31, 2022 | 19.72M |
| September 30, 2022 | 16.45M |
| June 30, 2022 | 15.97M |
| March 31, 2022 | 13.41M |
| December 31, 2021 | 12.31M |
| September 30, 2021 | 9.971M |
| June 30, 2021 | 7.80M |
| March 31, 2021 | 6.935M |
| December 31, 2020 | 6.248M |
| September 30, 2020 | 6.724M |
| June 30, 2020 | 6.82M |
| March 31, 2020 | 6.988M |
| December 31, 2019 | 6.90M |
| September 30, 2019 | 5.963M |
| June 30, 2019 | 6.426M |
| March 31, 2019 | 7.761M |
| December 31, 2018 | 8.738M |
| September 30, 2018 | 11.16M |
| Date | Value |
|---|---|
| June 30, 2018 | 13.48M |
| March 31, 2018 | 13.64M |
| December 31, 2017 | 14.12M |
| September 30, 2017 | 12.17M |
| June 30, 2017 | 11.73M |
| March 31, 2017 | 12.92M |
| December 31, 2016 | 14.92M |
| September 30, 2016 | 19.58M |
| June 30, 2016 | 22.00M |
| March 31, 2016 | 25.43M |
| December 31, 2015 | 29.67M |
| September 30, 2015 | 41.02M |
| June 30, 2015 | 53.85M |
| March 31, 2015 | 83.44M |
| December 31, 2014 | 100.24M |
| September 30, 2014 | 111.67M |
| June 30, 2014 | 119.77M |
| March 31, 2014 | 109.50M |
| December 31, 2013 | 109.72M |
| September 30, 2013 | 106.01M |
| June 30, 2013 | 104.18M |
| March 31, 2013 | 103.76M |
| December 31, 2012 | 101.52M |
| September 30, 2012 | 96.49M |
| June 30, 2012 | 94.17M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
6.248M
Minimum
Dec 2020
43.99M
Maximum
Sep 2024
18.13M
Average
14.69M
Median
Research and Development Expense (TTM) Benchmarks
| Mirum Pharmaceuticals Inc | 121.95M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |